Platelet leukocyte aggregates and markers of platelet aggregation, immune activation and disease progression in HIV infected treatment naive asymptomatic individuals

Journal of Thrombosis and Thrombolysis

Volumn 40, Issue 4, 2015, Pages 458-467

  Nkambule, Bongani B ^a   Davison, Glenda ^b   Ipp, Hayley ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b CAPE PENINSULA UNIVERSITY OF TECHNOLOGY   (South Africa)

Author keywords

HIV; Immune activation; Platelet activation; Platelet function; Platelet leukocyte aggregates

Indexed keywords

CD36 ANTIGEN; CD38 ANTIGEN; D DIMER; MEMBRANE PROTEIN; PADGEM PROTEIN; PROTEIN CD142; THROMBOPLASTIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BLOOD CLOTTING; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LEUKOCYTE ACTIVATION; LEUKOCYTE AGGREGATION; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; T LYMPHOCYTE; THROMBOCYTE AGGREGATION; VIRUS LOAD; BLOOD; CLINICAL TRIAL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; LEUKOCYTE; METABOLISM; MULTICENTER STUDY; PATHOLOGY; THROMBOCYTE;

ADULT; BIOMARKERS; BLOOD PLATELETS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES; MALE; PLATELET AGGREGATION;

EID: 84942505170     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-015-1212-8     Document Type: Article

References (38)

1. Ross AC, Rizk N, O’Riordan MA, Dogra V, EL-Bejjani D, Storer N, Harrill D, Tungsiripat M, Adell J, Mccomsey GA (2009) Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy. Clin Infect Dis 49(7):1119–1127
2. Cerletti C, De Gaetano G, Lorenzet R (2010) Platelet - leukocyte interactions: multiple links between inflammation, blood coagulation and vascular risk. Mediterr J Hematol Infect Dis 2(3):e2010023
3. Funderburg NT, Jiang Y, Debanne SM, Storer N, Labbato D, Clagett B, Robinson J, Lederman MM, Mccomsey GA (2014) Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapy. Clin Infect Dis 58(4):588–595
4. O’Brien M, Montenont E, Hu L, Nardi MA, Valdes V, Merolla M, Gettenberg G, Cavanagh K, Aberg JA, Bhardwaj N, Berger JS (2013) Aspirin attenuates platelet activation and immune activation in HIV-1-infected subjects on antiretroviral therapy: a pilot study. J Acquir Immune Defic Syndr (1999) 63(3):280–288
5. Beck Z, Jagodzinski LL, Eller MA, Thelian D, Matyas GR, Kunz AN, Alving CR (2013) Platelets and erythrocyte-bound platelets bind infectious HIV-1 in plasma of chronically infected patients. PLoS ONE 8(11):e81002
6. David R (2013) Host response: PF4—platelets’ poison. Nat Rev Microbiol 11(2):72–73
7. Speth C, Löffler J, Krappmann S, Lass-Flörl C, Rambach G (2013) Platelets as immune cells in infectious diseases. Future Microbial 8(11):1431–1451
8. Metcalf Pate KA, Lyons CE, Dorsey JL, Shirk EN, Queen SE, Adams RJ, Gama L, Morrell CN, Mankowski JL (2013) Platelet activation and platelet-monocyte aggregate formation contribute to decreased platelet count during acute simian immunodeficiency virus infection in pig-tailed macaques. J Infect Dis 208(6):874–883
9. Clark SR, Ma AC, Tavener SA, Mcdonald B, Goodarzi Z, Kelly MM, Patel KD, Chakrabarti S, Mcavoy E, Sinclair GD (2007) Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 13(4):463–469
10. Arazna M, Pruchniak MP, Zycinska K and Demkow U (2013) Neutrophil extracellular trap in human diseases. Respiratory Regulation-The Molecular Approach 1–8
11. De Gaetano G (2007) Determinants of platelet conjugate formation with polymorphonuclear leukocytes or monocytes in whole blood. Thromb Haemost 98:1276–1284
12. Bournazos S, Rennie J, Hart SP, Fox KA, Dransfield I (2008) Monocyte functional responsiveness after PSGL-1-mediated platelet adhesion is dependent on platelet activation status. Arterioscler Thromb Vasc Biol 28(8):1491–1498
13. Shi G, Morrell CN (2011) Platelets as initiators and mediators of inflammation at the vessel wall. Thromb Res 127(5):387–390
14. Reig G, Yeaman M, Lial A (2007) Platelet count is associated with plasma HIV type1 RNA and disease progression. AIDS res Hum Retroviral 23:1257–1261
15. Sarma J, Laan KA, Alam S et al (2002) Increased platelet binding to circulating monocytes in acute coronary syndromes. Circulation 105:2166–2171
16. Singh MV, Davidson DC, Kiebala M, Maggirwar SB (2012) Detection of circulating platelet–monocyte complexes in persons infected with human immunodeficiency virus type-1. J Virol Methods 181(2):170–176
17. Michelson AD, Barnard MR, Krueger LA, Robert Valeri C, Furman MI (2001) Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 104(13):1533–1537
18. Harding SA, Fau DJ, Sarma JF, Jessop AF, Weatherall M, Fox KAA, Newby DE (2007) Flow cytometric analysis of circulating platelet-monocyte aggregates in whole blood: methodological considerations. Thromb Haemost-Stuttgart 98(2):451
19. Tapp L, Shantsila E, Wrigley B, Montoro-Garcia S, LIP G (2013) TLR4 expression on monocyte subsets in myocardial infarction. J Intern Med 273(3):294–305
20. Nathan C (2006) Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 6(3):173–182
21. Cassol E, Malfeld S, Mahasha P, Van der merwe S, CASSOL S, Seebregts C, Alfano M, Poli G, Rossouw T (2010) Persistent microbial translocation and immune activation in HIV-1-infected South Africans receiving combination antiretroviral therapy. J Infect Dis 202(5):723–733
22. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, Kazzaz Z, Bornstein E, Lambotte O, Altmann D (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12(12):1365–1371
23. Nkambule BB, Davison G, Ipp H (2014) The value of flow cytometry in the measurement of platelet activation and aggregation in human immunodeficiency virus infection. Platelets 0:1–8
24. Pearson L, Thom J, Adams M, Oostryck R, Krueger R, Yong G, Baker R (2009) A rapid flow cytometric technique for the detection of platelet-monocyte complexes, activated platelets and platelet-derived microparticles. Int J Lab Hematol 31(4):430–439
25. Majumder B, North J, Mavroudis C, Rakhit R, Lowdell MW (2012) Improved accuracy and reproducibility of enumeration of platelet–monocyte complexes through use of doublet-discriminator strategy. Cytometry Part B 82(6):353–359
26. Nagasawa A, Matsuno K, Tamura S, Hayasaka K, Shimizu C, Moriyama T (2013) The basis examination of leukocyte–platelet aggregates with CD45 gating as a novel platelet activation marker. Int J Lab Hematol 35(5):534–541
27. Flaujac C, Boukour S, Cramer-Bordé E (2010) Platelets and viruses: an ambivalent relationship. Cell Mol Life Sci 67(4):545–556
28. Funderburg NT, Mayne E, Sieg SF, Asaad R, Jiang W, Kalinowska M, Luciano AA, Stevens W, Rodriguez B, Brenchley JM, Douek DC, Lederman MM (2010) Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation. Blood 115(2):161–167
29. Ziegler-Heitbrock L (2007) The CD14 CD16 blood monocytes: their role in infection and inflammation. J Leukoc Biol 81(3):584–592
30. Cros J, Cagnard N, Woollard K, Patey N, Zhang S, Senechal B, Puel A, Biswas SK, Moshous D, Picard C (2010) Human CD14 dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 33(3):375–386
31. IngersolL MA, Platt AM, Potteaux S, Randolph GJ (2011) Monocyte trafficking in acute and chronic inflammation. Trends Immunol 32(10):470–477
32. Cerletti C, Tamburrelli C, Izzi B, Gianfagna F, De Gaetano G (2012) Platelet-leukocyte interactions in thrombosis. Thromb Res 129(3):263–266
33. Podrez EA, Byzova TV, Febbraio M, Salomon RG, MA Y, ValiyaveettiL M, Poliakov E, Sun M, Finton PJ, Curtis BR (2007) Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype. Nat Med 13(9):1086–1095
34. Febbraio M, Hajjar DP, Silverstein RL (2001) CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Investig 108(6):785–791
35. Rahaman SO, Lennon DJ, Febbraio M, Podrez EA, Hazen SL, Silverstein RL (2006) A CD36-dependent signaling cascade is necessary for macrophage foam cell formation. Cell Metab 4(3):211–221
36. Ward JR, Bingle l, Judge HM, Brown SB, Storey RF, Whyte MK, Dower SK, Buttle DJ, Sabroe I (2005) Agonists of toll-like receptor (TLR) 2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor. Thromb Haemost 94:831–838
37. Aslam R, Speck ER, Kim M, Crow AR, Bang KW, Nestel FP, NI H, Lazarus AH, Freedman J, Semple JW (2006) Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo. Blood 107(2):637–641
38. Smith TL, Weyrich AS (2011) Platelets as central mediators of systemic inflammatory responses. Thromb Res 127(5):391–394